2021
DOI: 10.1016/j.neuroimage.2021.117913
|View full text |Cite
|
Sign up to set email alerts
|

Effects of SSRI treatment on GABA and glutamate levels in an associative relearning paradigm

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
27
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

4
5

Authors

Journals

citations
Cited by 25 publications
(31 citation statements)
references
References 111 publications
(136 reference statements)
1
27
0
Order By: Relevance
“…In a task-based fMRI analysis, neuronal activation was found to be decreased in the insula after relearning in subjects that were administered escitalopram (Reed et al, 2021). Further, we found a relationship between escitalopram and relearning when comparing glutamate levels in the hippocampus and thalamus before and after associative relearning (Spurny et al, 2021). These findings underline the effects of escitalopram and learning on various brain measures and we expected learning induced white matter changes.…”
Section: Discussionsupporting
confidence: 67%
See 1 more Smart Citation
“…In a task-based fMRI analysis, neuronal activation was found to be decreased in the insula after relearning in subjects that were administered escitalopram (Reed et al, 2021). Further, we found a relationship between escitalopram and relearning when comparing glutamate levels in the hippocampus and thalamus before and after associative relearning (Spurny et al, 2021). These findings underline the effects of escitalopram and learning on various brain measures and we expected learning induced white matter changes.…”
Section: Discussionsupporting
confidence: 67%
“…Study participants were randomly assigned to one of four groups prior to study inclusion as follows: SSRI: 17 character-group, 16 faces-group; Placebo: 15 character-group, 23 faces-group. The design has been described in detail in previously published studies (Reed et al, 2021;Spurny et al, 2021). In brief, diffusion MRI scans were carried out before and after an associative learning period of 3 weeks as well as after a subsequent 3-week associative relearning under SSRI/placebo treatment.…”
Section: Subjects and Study Designmentioning
confidence: 99%
“…Animal studies revealed a relationship between sex hormone receptors and the regulation of depressive-like behavior via the GABAergic system (Selakovic, 2019). While previous studies showed an impact of antidepressant treatment on hippocampal neurotransmitter levels (Silberbauer, 2020;Spurny, 2021), GHT follows similar patterns in mediating hippocampal neurotransmitter levels. Thus, GHT shows properties to influence hippocampal neuronal networks that were shown to be involved in MDD and other psychiatric diseases on a molecular level via hormone receptors and changes in BDNF levels.…”
Section: Discussionmentioning
confidence: 95%
“…Modifications of neurotransmitter systems are key aspects of the antidepressant actions of different interventions in order to restore GABAergic or glutamatergic function (Kalueff and Nutt, 2007 ; Sanacora et al, 2012 ). Several studies have shown SSRIs or ketamine to affect a variety of neurotransmitter systems including the serotonergic (Spindelegger et al, 2009 ; Hahn et al, 2010 ; Lanzenberger et al, 2012 ), GABAergic (Sanacora et al, 2002 ; Brennan et al, 2017 ; Silberbauer et al, 2020 ) or the glutamatergic system (Rowland et al, 2005 ; Taylor et al, 2008 ; Spurny et al, 2021 ). Moreover, certain antidepressants directly interfere with the glutamatergic or GABAergic system.…”
Section: Introductionmentioning
confidence: 99%